SCL Science

At a glance

SCL Science filed 36 disclosures in the last 12 months, including 3 insider, 3 5% holder, 2 m&a and 1 contract. The most recent key filing was on Oct 29.

Revenue for 2025 was ₩22B, up 364.6% on 2024. It made an operating loss of ₩3.4B. Debt was 240% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩15.3B and operating loss of ₩242M.

The 2025 annual report lists 163 employees with an average tenure of 1.3 years and average pay of ₩77.3M, #434 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩85.7M each on average. It paid no cash dividend for 2025. 주식회사 에스씨엘홀딩스 and related parties held 48.85% at year end.

From the 2025 annual report

Staff: 163 (126 men, 37 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩5.1B. Directors and auditors: 6, paid ₩514.2M in total.

No cash dividend was paid for 2025.

Largest shareholder

주식회사 에스씨엘홀딩스 holds 35.63%; with 1 related party the group holds 48.85% of common shares at year end (from 40.64% at the start of the year).

Auditor: 안진회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

1 new supply contract worth 35% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary